Early and persistent high level of PS 100β is associated with increased poor neurological outcome in patients with SAH: is there a PS 100β threshold for SAH prognosis?
Crossref DOI link: https://doi.org/10.1186/s13054-016-1200-1
Published Online: 2016-02-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Quintard, Hervé
Leduc, Sébastien
Ferrari, Patricia
Petit, Isabelle
Ichai, Carole
Text and Data Mining valid from 2016-02-03
Version of Record valid from 2016-02-03
Article History
Received: 20 November 2015
Accepted: 16 January 2016
First Online: 3 February 2016